Surgery (non-interventional, standard of care)

PROCEDURE2 trials

Sponsors

Sue Yom, University of California, San Francisco

Conditions

Non Small Cell Lung CancerOral Cavity Squamous Cell Carcinoma

Phase 1

Nisin in Oral Cavity Squamous Cell Carcinoma (OCSCC)

RecruitingNCT06097468

University of California, San FranciscoOral Cavity Squamous Cell Carcinoma

Start: 2024-02-02End: 2028-10-01Target: 40Updated: 2026-04-13

Phase 2

Pembrolizumab With and Without Radiotherapy for Non-Small Cell Lung Cancer

CompletedNCT03217071

Sue YomNon Small Cell Lung Cancer

Start: 2017-10-04End: 2022-03-31Updated: 2024-10-23

Related Papers

[Application of Neoadjuvant Immuno-chemotherapy in NSCLC].

2021-04-015 citations

Neoadjuvant anti-programmed Death-1 immunotherapy by Pembrolizumab in resectable nodal positive stage II/IIIa non-small-cell lung cancer (NSCLC): the NEOMUN trial.

2019-05-0256 citations